Emerging role of recombinant factor VIIa in neuroscience

AACN Advanced Critical Care

Volumn 17, Issue 4, 2006, Pages 363-367

  Alexander, Earnest ^a  

^a TAMPA GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; RECOMBINANT PROTEIN;

BRAIN HEMORRHAGE; HUMAN; PATHOPHYSIOLOGY; REVIEW;

CEREBRAL HEMORRHAGE; FACTOR VIIA; HUMANS; RECOMBINANT PROTEINS;

EID: 33845689362     PISSN: 15597768     EISSN: 15597768     Source Type: Journal    
DOI: 10.1097/01256961-200610000-00001     Document Type: Review

References (8)

1. Badjatia N, Rosand J. Intracerebral hemorrhage. Neurologist. 2005;11:311-324.
2. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
3. Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke. 1999;30:905-915.
4. Package insert. NovoSeven® (Recombinant Factor VIIa). Princeton, NJ: Novo Nordisk Inc; 2005.
5. Villar A, Aronis S, Morfini M, et al. Pharmacokinetics of activated recombinant coagulation factor VII (Novo-Seven) in children versus adults with hemophilia A. Haemophilia. 2004;10:352-359.
6. Mayer SA, Brun NC, Broderick J, et al. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. 2005;36:74-79.
7. Mayer SA, Brun NC, Broderick J, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
8. Roitberg B, Emechebe-Kennedy O, Amin-Hanjani S, et al. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study. Neurosurgery. 2005;57:832-835.